top of page
PHARMACEUTICALS
Exporting high-quality medicines, trusted by doctors to 27 countries across the globe.
Our pharmacuetical division , Glatzo stands as a beacon of reliability in pharmaceutical exports and supplement manufacturing. Our operations are anchored in a steadfast commitment to regulatory compliance, ethical sourcing, and timely global delivery. Our core strength lies in our ability to procure and export a vast portfolio of finished pharmaceutical formulations, over-the-counter (OTC) products, essential medical consumables, and innovative health supplements.
Leveraging our profound understanding of international markets and robust industry partnerships, we offer our global clientele seamless access to cost-effective, high-quality products. This is complemented by our meticulous logistics management and comprehensive documentation support, ensuring a smooth and efficient supply chain
Delivering the world’s most affordable medicines.Empowering global healthcare with accessibility, quality, and compassion
We are a globally trusted manufacturer and marketer of a diverse range of pharmaceutical formulations catering to both chronic and acute therapies. Our portfolio encompasses generics, branded generics, specialty and complex products, over-the-counter (OTC) medicines, antiretrovirals (ARV), Active Pharmaceutical Ingredients (API), and intermediates.
With an extensive range of dosage forms—including tablets, capsules, injectables, inhalers, ointments, creams, and liquids—we deliver billions of doses every year across major therapeutic areas such as neuropsychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology, and respiratory care. Through this, we are continually enhancing global access to high-quality, affordable medicines.
As pioneers among Indian pharmaceutical companies in recognizing and prioritizing innovation, we allocate 6–8% of our global revenues annually toward Research and Development (R&D). Our dedicated team of over 1400 R&D professionals brings strong expertise in formulations, process chemistry, and analytical development. Our core strength lies in the creation of generics and technologically advanced products. We specialize in differentiated drug delivery systems such as liposomal formulations, inhalers, lyophilized injections, nasal sprays, and controlled-release dosage forms reflecting our deep commitment to innovation and excellence.
From our humble inception in 2010, we have evolved into one of the world’s leading specialty generic pharmaceutical companies and India’s No. 1 pharma brand. In the United States, we rank among the top specialty generic companies and hold the No. 2 position in generic dermatology prescriptions. With a strong presence in over 80 countriesincluding key markets across Brazil, Mexico, Russia, Romania, and South Africa—we have established a significant global footprint spanning Western Europe, Canada, Australia, New Zealand, Israel, and Japan.
Glatzo has built a portfolio of patent protected speciality medicines for global markets. Over the years, we have nurtured this evolving business through increased focus and investments. The key segments we are targeting are dermatology, ophthalmology and oncology. Our focus is on improving patient outcomes either by addressing unmet medical needs or by enhancing patient convenience through differentiated dosage forms. Our initiatives in this segment cover the entire value chain, from in-licensing early-to-late stage clinical candidates, as well as getting access to on-market patented products. Today, we are among the leading branded companies in the US with several speciality products launched in the country.
Generic Medications
We deliver high-quality generic and branded pharmaceuticals at affordable prices, reaching patients and healthcare professionals across more than 27 countries worldwide. Our product portfolio is defined by technology-driven innovation and spans an extensive range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
With a diverse portfolio of over 2,000 molecules, we cater to a wide spectrum of therapeutic segments such as psychiatry, neurology, cardiology, orthopaedics, diabetology, gastroenterology, anti-infectives, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental care, and nutritionals. Across several global markets, we consistently rank among the leading pharmaceutical companies within these therapeutic domains.
Anti Retro Viral Medications
We offer a wide range of WHO prequalified ARV medicines. Improving access and affordability is our key objective. We supply ARVs to various National AIDS treatment programs in Africa.
Our portfolio comprises bio-equivalent ARV medicines and Active Pharmaceutical Ingredients (API) manufactured at our state-of-the-art WHO prequalified manufacturing facilities in India, a PIC/S approved manufacturing facility in South Africa and a facility in Russia. Indeed, with several first-line and second line Highly Active Antiretroviral Therapy (HAART) regimens in our portfolio, we hope to contribute significantly to combating HIV/AIDS.
bottom of page